Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Clinical Data
Special Reports
2021's top 10 clinical trial flops
Thousands of studies are registered each year, so there is always an array of disappointing results to choose from for our annual top 10 list.
Phil Taylor
Mar 1, 2022 3:00am
Agenus gets boost for combo drug, this time in ovarian cancer
Mar 27, 2023 9:45am
66-week data put AstraZeneca on route to rare disease approval
Mar 27, 2023 4:44am
VistaGen's social anxiety nasal spray finds open-label success
Mar 22, 2023 3:36pm
89bio hits primary goals in midphase NASH trial, plots phase 3
Mar 22, 2023 8:31am
Astellas' drug against hot cancer target hits again in phase 3
Mar 22, 2023 6:30am
More News
Selecta, Sobi rout gout in phase 3 trials to take on Horizon
Mar 21, 2023 7:40am
Hype builds for Karuna's schizophrenia drug with phase 3 data
Mar 20, 2023 12:03pm
Takeda's $4B drug clears psoriasis in one-third of patients
Mar 20, 2023 8:15am
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Mar 17, 2023 10:11am
See more stories
